G. Hufnagel

发表

Pericardioscopy and epicardial biopsy--new diagnostic tools in pericardial and perimyocardial disease.

M. Herzum, B. Maisch, C. Bethge, 1994, European heart journal.

The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID).

C. Hengstenberg, B. Maisch, C. Hengstenberg, 1995, European heart journal.

Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour holter electrocardiography.

W. Grimm, B. Maisch, H. Müller, 2000, American heart journal.

Immunosuppressive and immunomodulatory treatment for myocarditis.

M. Herzum, B. Maisch, G. Hufnagel, 1996, Current opinion in cardiology.

Expression of MHC class I and II antigens and the Il-2 receptor in rejection, myocarditis and dilated cardiomyopathy.

B. Maisch, G. Hufnagel, 1991, European heart journal.

Treatment of Inflammatory Dilated Cardiomyopathy and (Peri)Myocarditis with Immunosuppression and i.v. Immunoglobulins

G. Hufnagel, M. Herzum, B. Maisch, 2004, Herz.

[The extracellular matrix and cytoskeleton of the myocardium in cardiac inflammatory reaction].

C. Hengstenberg, C. Brilla, M. Herzum, 1995, Herz.

Intrapericardial treatment of inflammatory and neoplastic pericarditis guided by pericardioscopy and epicardial biopsy—results from a pilot study

C. Brilla, W. Grimm, M. Herzum, 1999, Clinical cardiology.

Prognostic determinants in conventionally treated myocarditis and perimyocarditis--focus on antimyolemmal antibodies.

C. Hengstenberg, M. Herzum, B. Maisch, 1991, European heart journal.

Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens.

B. Maisch, S. Pankuweit, U. Baandrup, 2003, Human pathology.

Immunosuppressive Treatment for Inflammatory Dilated Cardiomyopathy (Myocarditis)

M. Herzum, B. Maisch, C. Bethge, 1998 .

Immunosuppressive treatment for myocarditis and dilated cardiomyopathy.

M. Herzum, B. Maisch, C. Bethge, 1995, European heart journal.

Immunosuppressive treatment in autoreactive myocarditis--results from a controlled trial.

C. Hengstenberg, M. Herzum, B. Maisch, 1994, Postgraduate medical journal.

Pathophysiology of viral myocarditis: the role of humoral immune response.

A. Ristic, B. Maisch, S. Pankuweit, 2002, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Humoral and Cell-Mediated Immunity: Pathogenetic Mechanisms in Dilated Cardiomyopathy

M. Herzum, B. Maisch, S. Nunoda, 1990 .

Cytokine Activation in Pericardial Fluids in Different Forms of Pericarditis

B. Maisch, S. Pankuweit, E. Meyer, 2000, Herz.

Arrhythmias in Acute Pericarditis

P. Seferovic, A. Ristic, E. Olsen, 2000 .

Are Anti-cardiac Antibodies in Dilated Cardiomyopathy “Natural” Antibodies?

M. Herzum, B. Maisch, S. Pankuweit, 1993 .

Are antisarcolemmal (ASAs) and antimyolemmal antibodies (AMLAs) "natural" antibodies?

C. Hengstenberg, M. Herzum, B. Maisch, 1991, Basic research in cardiology.

The group B coxsackieviruses and myocarditis

N. Chapman, S. Tracy, G. Hufnagel, 2001, Reviews in medical virology.

Dilated Cardiomyopathies as a Cause of Congestive Heart Failure

A. Ristic, B. Maisch, P. Alter, 2002, Herz.

Arrhythmias in Acute Pericarditis An Endomyocardial Biopsy Study

P. Seferovic, A. Ristic, E. Olsen, 2000, Herz.

[Prevention of atrial arrhythmias by pacing].

W. Grimm, B. Maisch, R. Funck, 2001, Herz.

Autoimmunity in dilated cardiomyopathy

M. Herzum, B. Maisch, Bernhard Maisch, 1996, Heart Failure Reviews.

[Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation].

B. Maisch, S. Pankuweit, H. Eckhardt, 1998, Medizinische Klinik.

[Immunoserologic and immunohistologic studies of myocarditis and pericarditis].

M. Herzum, B. Maisch, G. Hufnagel, 1995, Der Internist.

Cytolytic anticardiac membrane antibodies in the pathogenesis of myopericarditis.

C. Hengstenberg, B. Maisch, D. Schwab, 1992, Postgraduate medical journal.

[Prospective evaluation of effect of carvedilol therapy on heart rate variability in patients with dilated cardiomyopathy].

W. Grimm, B. Maisch, V. Menz, 1999, Zeitschrift fur Kardiologie.

The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region

K. Currey, N. Chapman, S. Tracy, 1995, Journal of virology.

The vascular endothelium as target of humoral auto-reactivity in myocarditis and rejection.

C. Hengstenberg, A. Haverich, B. Maisch, 1989, Zeitschrift fur Kardiologie.

Mitral, aortic and tricuspid valvular heart disease associated with ergotamine therapy for migraine.

B. Maisch, A. Wilke, H. Hesse, 1997, European heart journal.

The use of endomyocardial biopsy in heart failure.

B. Maisch, U. Pfeifer, G. Hufnagel, 1988, European heart journal.

Value of immunohistological and immunoserological monitoring in cardiac transplantation

H. Schäfers, A. Haverich, B. Maisch, 1987 .